Smooth Drug Development April 2024 News Release

We are working on the following new projects:

• Semaglutide trial was awarded to SDD.
• We started three full services projects for bioequivalence studies with Duloxetine and Nimesulide. 
• Smooth received two contracts for medical writing services for the Rilpivirine and Cabotegravir projects.
• We launched a bioequivalence trial with Liraglutide.

We are happy to reach the following milestones in our projects:

• 25 patients were randomized in a phase III clinical trial in paroxysmal nocturnal hemoglobinuria.
• An enrollment was finished in the phase II trial in flu.